AGENUS INC Total Contract Liability
AGENUS INC (AGEN) had Total Contract Liability of $1.14 million as of 2026-03-31, per its 10-Q filed 2026-05-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-05-11
- 2026-03-31: Contract with Customer, Liability $1.14M.
- 2025-12-31: Contract with Customer, Liability $1.14M.
- 2025-09-30: Contract with Customer, Liability $1.19M.
- 2025-06-30: Contract with Customer, Liability $1.19M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2026-03-31 | $1.14M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $1.14M 10-Q · filed 2026-05-11 |
| 2025-09-30 | $1.19M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $1.19M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $1.16M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.17M 10-K · filed 2026-03-16 |
| 2024-09-30 | $1.15M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.15M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.16M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.16M 10-K · filed 2025-03-17 |
| 2023-09-30 | $6.14M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $8.97M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $11.03M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $13.41M 10-K · filed 2024-03-14 |
| 2022-09-30 | $15.83M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $20.37M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $22.21M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $23.63M 10-K · filed 2023-03-16 |
| 2021-09-30 | $24.94M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $42.83M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $44.23M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $45.28M 10-K · filed 2022-03-01 |
| 2020-09-30 | $47.77M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $51.92M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $54.58M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $56.41M 10-K · filed 2021-03-16 |
| 2019-09-30 | $64.87M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $55.18M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $59.09M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $2.05M 10-K · filed 2020-03-16 |
| 2018-09-30 | $2.31M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $2.58M 10-Q · filed 2018-08-09 |
| 2017-12-31 | $3.38M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |